Draig Therapeutics Ltd
Clinical trials sponsored by Draig Therapeutics Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New depression drug DT-101 enters Mid-Stage trial Results expected May 2027 (estimated)
- New depression drug DT-101 enters Mid-Stage trial Results expected Aug 2027 (estimated)
-
New depression drug DT-101 enters Mid-Stage trial
Symptom relief Recruiting nowThis phase 2 trial tests whether DT-101 can ease depression symptoms in adults with major depressive disorder who are already on antidepressant medication. About 118 participants will receive either DT-101 or a placebo, and researchers will track changes in depression scores over…
Phase 2 • Sponsor: Draig Therapeutics Ltd • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
New depression drug DT-101 enters Mid-Stage trial
Symptom relief Recruiting nowThis Phase 2 trial tests whether DT-101 can reduce depression symptoms in adults with major depressive disorder. About 300 participants will receive either DT-101 or a placebo for 6 weeks, and researchers will track mood changes using standard depression scales. The study is curr…
Phase 2 • Sponsor: Draig Therapeutics Ltd • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC